Skip to content

The effectiveness of Mindful Hypnotherapy on psychological aspects and severity of headache in patients with chronic migraine

The effectiveness of hypnosis-based mindfulness therapy on psychological aspects and severity of headache in patients with chronic migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201009048974N2
Enrollment
38
Registered
2022-01-21
Start date
2021-12-22
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic migraine headache. Chronic migraine without aura, not intractable, with status migrainosus

Interventions

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Having chronic migraine headaches according to the International Headache Committee (IHS) and the beta version of the Third International Classification of Headache Disorders (ICHD-3 beta) Having informed consent to participate in the research and signing the informed consent form Age range between 18 and 50 years At least a diploma degree Female gender

Exclusion criteria

Exclusion criteria: Having other chronic pain problems Have a history of psychotherapy in the last 6 months Participate in another psychological intervention simultaneously Recent drugs abuse Existence of diagnostic indicators or history of borderline personality disorder, psychosis or schizophrenia due to interference with hypnosis History of epileptic seizures or facial nerve pain

Design outcomes

Primary

MeasureTime frame
Psychological inflexibility. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Psychological Inflexibility Pain Scale (PIPS).;Pain Acceptance. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Pain acceptance questionnaire (CPAQ).;Pain Anxiety. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Pain Anxiety Symptoms Scale (PASS-20).;Pain Catastrophizing. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Pain Catastrophizing Scale (PCS).;Mindfulness. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Five Facet Mindfulness Questionnaire (FFMQ).;Self-Compassion. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Self-Compassion Scale (SCS).;Emotion Regulation. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Emotion Regulation Strategies Questionnaire (ERQ).;Psychological Distress. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Kessler Psychological Distress Scale (K10).;Headache related disability. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Headache related disability questionnaire (HDI).;Headache intensity. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Visual Analogue Scale (VAS), McGill Pain Questionnaire (MPQ), Blanchard headache diary.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Khazraee

Shahid Beheshti University of Medical Sciences

hassankhazraee@gmail.com+98 21 2293 5548

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026